Reprogramming immunity: designing smarter checkpoint receptor agonists
29 May 2025 | By Eurofins DiscoverX
Dr Daniela Cipolletta from Seismic Therapeutic explores how FcγRIIb clustering enabled the discovery of S-4321, a low-affinity PD-1 agonist that restores immune balance by engaging multiple inhibitory pathways.